Showing results (901-910 of 1,120) with videos related to

Sort By:
Pageof 112
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
JACC. Advances|April 27, 2025
Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol LevelsSem A O F Rikken, C Michael Gibson, M Cecilia Bahit, et al.
Journal of the American College of Cardiology|December 15, 2025
Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized TrialVagner Madrini, Paulo Vinicius Ramos Souza, Fabio Fernandes, et al.
Frontiers in Medicine|March 29, 2021
Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman SyndromeAlessandra G D Lopes, Camila S H Celestino, Tiago T A Barros, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
JAMA Cardiology|April 1, 2020
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical TrialHarmony R Reynolds, Leslee J Shaw, James K Min, et al.
The American Journal of Cardiology|December 17, 2023
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical TrialsRemo H M Furtado, Pedro G M Barros E Silva, Henrique A R Fonseca, et al.
Frontiers in Cardiovascular Medicine|August 13, 2021
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA TrialRenata Moll-Bernardes, Andrea Silvestre de Sousa, Ariane V S Macedo, et al.
American Heart Journal|September 4, 2021
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE TrialEduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, et al.
JAMA|January 18, 2022
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialJeffrey S Berger, Lucy Z Kornblith, Michelle N Gong, et al.
Pageof 112